Trademark: 87693311
Word
LAINGAX
Status
Dead
Status Code
606
Status Date
Monday, July 12, 2021
Serial Number
87693311
Mark Type
4000
Filing Date
Tuesday, November 21, 2017
Published for Opposition
Tuesday, April 10, 2018
Abandoned Date
Monday, July 12, 2021

Trademark Owner History
Tanvex BioPharma, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments

Trademark Events
Jul 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 12, 2021
Abandonment - No Use Statement Filed
Dec 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2020
Extension 5 Granted
Nov 12, 2020
Extension 5 Filed
Nov 23, 2020
Case Assigned To Intent To Use Paralegal
Nov 12, 2020
Teas Extension Received
May 13, 2020
Notice Of Approval Of Extension Request E-Mailed
May 11, 2020
Extension 4 Granted
May 11, 2020
Extension 4 Filed
May 11, 2020
Teas Extension Received
Nov 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 6, 2019
Extension 3 Granted
Nov 6, 2019
Extension 3 Filed
Nov 6, 2019
Teas Extension Received
Jun 17, 2019
Teas Change Of Correspondence Received
May 10, 2019
Notice Of Approval Of Extension Request E-Mailed
May 8, 2019
Extension 2 Granted
May 8, 2019
Extension 2 Filed
May 8, 2019
Teas Extension Received
Nov 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2018
Extension 1 Granted
Nov 5, 2018
Extension 1 Filed
Nov 5, 2018
Teas Extension Received
Jun 5, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 10, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 10, 2018
Published For Opposition
Mar 21, 2018
Notification Of Notice Of Publication E-Mailed
Mar 8, 2018
Approved For Pub - Principal Register
Mar 6, 2018
Assigned To Examiner
Dec 4, 2017
New Application Office Supplied Data Entered In Tram
Nov 24, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24